GlaxoSmithKline (GSK) pleaded guilty to criminal charges in 2012 and 2016. In 2012, GSK agreed to pay $3 billion in fines and plead guilty to criminal charges related to the illegal promotion of prescription drugs, including Paxil and Wellbutrin. In 2016, GSK pleaded guilty to charges related to the manufacturing and distribution of adulterated drugs at its Puerto Rico facility and agreed to pay $20 million in fines.